Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Voice Disorders 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Pleural Diseases 1Papilloma 1Ototoxicity 1Non-Muscle Invasive Bladder Neoplasms 1Mesothelioma 1Laryngeal Neoplasms 1Hearing Loss 1Head and Neck Neoplasms 1Goiter 1

Interventions

sodium thiosulfate 1ebselen 1Tomography, X-Ray Computed 1Sodium Chloride 1Magnetic Resonance Imaging 1Hyaluronic Acid 1Hearing Tests 1Genetic Association Studies 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hearing Loss × Hyaluronic Acid × Clear all
NCT04262336 2023-07-06

Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment

Decibel Therapeutics

Phase 1 Completed
22 enrolled

Ototoxicity, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡